What is the recommendation for precatheterization triple antiplatelet therapy for high-risk patients?
Precatheterization triple antiplatelet therapy (ASA, clopidogrel or ticagrelor, GP inhibitors) is a Class IIb, LOE: B recommendation for selected high-risk patients.